Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.4979 in Restless Legs Syndrome
2013-004884-30Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in restless legs syndrome (RLS) comparing BP1.4979 15 mg BID with Placebo (2 arms). Primary endpoint: Change in PLMS index. Started Jan 2018; status: completed.
02
Drugs
BP-1.4979
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2013-004884-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004884-30.